Kymentie Ferdinande: Rivaroxaban in Cirrhosis and the Path Toward Individualized Anticoagulation
Kymentie Ferdinande, PhD Researcher UNIPD at University of Padova, shared a post on LinkedIn about a recent article she and her colleagues co-authored, adding:
“We are pleased to share our Letter to the Editor in Journal of Thrombosis and Haemostasis (JTH) commenting on the recent work by Cindy Pereira Portela, Lorenzo Alberio and colleagues on the effect of direct oral anticoagulants in cirrhosis.
In this letter, we present complementary in vitro data on rivaroxaban in cirrhosis, in line with those of Portela et al.. Together, these observations support the need for more individualized anticoagulation strategies in cirrhosis, an area that warrants further investigation.
Many thanks to the authors for their interesting reply!”
Title: “Effect of direct oral anticoagulants in cirrhosis: an in vitro study”: comment
Authors: Kymentie Ferdinande, Jill Vercruyssen, Jochen Decaestecker, Charlotte De Vloo, Inge Van Haute, Helena Degroote, Sarah Raevens, Xavier Verhelst, Anja Geerts, Hans Van Vlierberghe, Katrien M. J. Devreese
Read the Full Article on Journal of Thrombosis and Hemostasis

Stay updated on all scientific advances with Hemostasis Today.
-
Jun 24, 2026, 03:36Ana Pedrero Gil: A New Approach to Post-Tonsillectomy Hemorrhage
-
Jun 24, 2026, 02:59Melissa Hollo: Making Early Anemia Detection the Standard of Care
-
Jun 24, 2026, 02:51Bruno Pougault: The Thin Line Between Bleeding and Clotting
-
Jun 23, 2026, 23:30Shunsuke Iwano: PMDA Introduces Greater Flexibility for Pediatric Factor VIII and IX Development in Japan
-
Jun 23, 2026, 23:05Rounak Dubey: ISBT Academy Session on Agentic AI
-
Jun 23, 2026, 22:59Mohammed Maher Babiker: When ‘Low Platelets’ aren’t Really Low
-
Jun 23, 2026, 22:49Giovanni Merlino: Why Does Stress Hyperglycemia Worsen Stroke Outcomes?
-
Jun 23, 2026, 22:41Tareq Abadl: Coombs Test – The Key to Detecting Immune-Mediated Hemolysis
-
Jun 23, 2026, 22:32How WFH Impacted the Bleeding Disorders Community in 2025